2016 HCPCS Q0162
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

  • Added on Sunday, January 01, 2012
  • Status changed on Sunday, January 01, 2012 to: No maintenance for this code
  • BETOS Classification: Chemotherapy
  • Medicare coverage status: Special coverage instructions apply

  Q0161    Q0163